Viewing Study NCT07410559


Ignite Creation Date: 2026-03-26 @ 3:14 PM
Ignite Modification Date: 2026-03-30 @ 9:20 PM
Study NCT ID: NCT07410559
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-02-18
First Post: 2026-02-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Breast Cancer
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module